Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment

British Medical Journal, Jan 16, 1999 by Alison Perry, Nicholas Tarrier, Richard Morriss, Eilis McCarthy, Kate Limb

[4] Tohen M, Waternaux GM, Tsuang MT. Outcome in mania: a 4 year prospective follow-up of 75 patients utilising survival analysis. Arch Gen Psychiatry 1990:47:1106-11.

[5] Keller MB, Lavori PW, Coryell W, Endicott J, Mueller TI. Bipolar I: a five year prospective follow up. J Nerv Ment Dis 1993;181:238-45.

[6] Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry 1995;152:1635-40.

[7] Keck PE, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, et al. 12 month outcome of patients with bipolar disorder following hospitalisation for a manic or mixed episode. Am J Psychiatry 1998;155: 646-52.

[8] Molnar G, Feeney M, Fava G. The duration and symptoms of bipolar prodromes. Am J Psychiatry 1988;145:1575-8.

[9] Smith J, Tarrier N. Prodromal symptoms in manic depressive psychosis. Soc Psychiatry Psychiatric Epidemiol 1992;27:245-8.

[10] Lam D, Wong G. Prodromes, coping strategies, insight and social functioning in bipolar affective disorders. Psychol Med 1997;27:1091-100.

[11] Altman ES, Rea MM, Mintz J, Miklowik DJ, Goldstein MJ, Hwang S. Prodromal symptoms and signs of bipolar relapse: a report based on prospectively collected data. Psychiatr Res 1992;41:1-8.

[12] Keller MB, Lavori PW, Kane JM, Gelenberg AJ, Rosenbaum JF, Walzer EA, et al. Subsyndromal symptoms in bipolar disorder: a comparison of standard and low serum levels of lithium. Arch Gen Psychiatry 1982;49:371-6.

[13] Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical interview for DSM-III-R, patient edition. Washington, DC: APA, 1990.

[14] Pocock ST. Clinical trials: a practical guide. Chichester: Wiley, 1983.

[15] Kessing LV. Recurrence in affective disorder. II. Effect of age and gender. Br J Psychiatry 1998;172:29-34.

[16] Maj M, Pirozzi R, Magliano L, Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 1998;155:30-6.

[17] Miklowitz D, Goldstein M, Nuechterlein K, Snyder M, Mintz J. Family factors and the course of bipolar affective disorders. Arch Gen Psychiatry 1988;45:225-30.

[18] Perry A, Tarrier N, Morriss R. Identification of prodromal signs and symptoms and early intervention in manic depressive psychosis patients: a case example. Behav Cognit Psychother 1995;23:399-409.

[19] Young MA, Grabler P. Rapidity of symptom onset in depression. Psychiatr Res 1985;16:309-15.

[20] Hurry J, Sturt E, Bebbington P, Tennant C. Socio-demographic associations with social disablement in a community sample. Soc Psychiatry 1983;18:113-21.

[21] World Health Organisation. Anatomical therapeutic chemical (ATC) classification index including defined daily doses (DDDs) per plan substances. Oslo: WHO Collaborating Centre for Drug Statistics and Methodology, 1994.

[22] Hlastala SA, Frank E, Mallinger AG, Thase ME, Ritenour AM, Kupfer DJ. Bipolar depression: an underestimated treatment challenge. Depression Anxiety 1997;5:73-83.

[23] Gater RA, Dean C, Morris J. The contribution of childbearing to the sex difference in first admission rates for affective psychosis. Psychol Med 1989;19:719-24.